Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas

Implications for Health Policy

Marcos A. Espinal, MD, DrPH; Jon K. Andrus, MD; Barbara Jauregui, MD, MSc; Stephen Hull Waterman, MD, MPH; David Michael Morens, MD; Jose Ignacio Santos, MD, MSc; Olaf Horstick, PhD (DrMed), FFPH, MPH, MSc, MBBS; Lorraine Ayana Francis, DrPH, MHA; Daniel Olson, MD


Am J Public Health. 2019;109(3):387-392. 

In This Article


In June 2018, the George Washington University Milken Institute of Public Health convened a Global Arbovirus Group of Experts, including leading international and regional experts from PAHO, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Center for Global Health at the University of Colorado, among others, to discuss current challenges for Aedes-transmitted arbovirus infections in the Americas. The Global Arbovirus Group of Experts issued the following technical recommendations with the overriding priority to prevent unnecessary morbidity and mortality of arbovirus infections: Cases need to be detected earlier so essential clinical and public health interventions can be implemented in a more timely fashion. To that end, efforts to improve the following will be critical: laboratory capacity and diagnostics, case reporting and management, integrated surveillance system with an emphasis on data quality, and community communication to minimize exposures. Research, including that for vaccine development, improved diagnostics, and operational research for best practices such as vector control within an integrated approach and vaccination achieving high coverage rates among communities most at risk will also be essential. A more detailed list of recommendations is included as Appendix A (available as a supplement to the online version of this article at http://www.ajph.org).